Next Article in Journal
Potential Antibacterial Activity of Carvacrol-Loaded Poly(DL-lactide-co-glycolide) (PLGA) Nanoparticles against Microbial Biofilm
Previous Article in Journal
Investigation of the Structure Requirement for 5-HT6 Binding Affinity of Arylsulfonyl Derivatives: A Computational Study
Int. J. Mol. Sci. 2011, 12(8), 5031-5038; doi:10.3390/ijms12085031
Article

Comparative Clinical Study of Bactigras and Telfa AMD for Skin Graft Donor-Site Dressing

1
, 1
 and 2,*
Received: 24 April 2011; in revised form: 22 July 2011 / Accepted: 1 August 2011 / Published: 8 August 2011
(This article belongs to the Section Material Sciences and Nanotechnology)
View Full-Text   |   Download PDF [258 KB, updated 19 June 2014; original version uploaded 19 June 2014]   |   Browse Figure
Abstract: The Bactigras® paraffin tulle coated with chlorhexidine is normally used for the treatment of donor-site wounds in burn patients who received split-thickness skin grafts in several centers. It has some disadvantages, such as adhesion to wound surfaces and pain from the irritation caused by this dressing. The Telfa AMD®, a non-adherent wound dressing which consists of absorbent cotton fibers impregnated with polyhexamethylene biguanide enclosed in a sleeve of thermoplastic polymers, is a new option for donor-site wound care which causes less adherence to the wound. The purpose of this study was to compare clinical efficacy of these two dressings for the management of donor-site wounds. Thirty-two patients who received split-thickness skin grafts by donor site harvesting from the thigh were enrolled in this study and randomized into two groups receiving either the Bactigras® or the Telfa AMD® wound treatment. Re-epithelialization, pain, infection and cost-effectiveness analyses were compared between both groups. The results showed that there was no significant difference in age, area of donor sites or length of hospital stays between the groups (p > 0.05). However, the day of re-epithelialization (≥90%) was significantly shorter in patients treated with the Telfa AMD® compared to the Bactigras® group (14.00 ± 3.05 vs. 9.25 ± 1.88 days for Bactigras® and Telfa AMD® groups, respectively, p < 0.001). The average pain score was also significantly lower in the Telfa AMD® group (1.57 ± 0.55 vs. 4.70 ± 1.16, p < 0.001). There was no difference in the cost of treatment between the groups (4.64 ± 1.97 vs. 5.72 ± 2.54 USD, p = 0.19). This study indicated that the Telfa AMD® was an effective dressing for the treatment of donor-site wounds.
Keywords: Bactigras; burn; chlorhexidine; donor site wound; polyhexamethylene biguanide; Telfa AMD Bactigras; burn; chlorhexidine; donor site wound; polyhexamethylene biguanide; Telfa AMD
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Muangman, P.; Nitimonton, S.; Aramwit, P. Comparative Clinical Study of Bactigras and Telfa AMD for Skin Graft Donor-Site Dressing. Int. J. Mol. Sci. 2011, 12, 5031-5038.

AMA Style

Muangman P, Nitimonton S, Aramwit P. Comparative Clinical Study of Bactigras and Telfa AMD for Skin Graft Donor-Site Dressing. International Journal of Molecular Sciences. 2011; 12(8):5031-5038.

Chicago/Turabian Style

Muangman, Pornprom; Nitimonton, Sooksan; Aramwit, Pornanong. 2011. "Comparative Clinical Study of Bactigras and Telfa AMD for Skin Graft Donor-Site Dressing." Int. J. Mol. Sci. 12, no. 8: 5031-5038.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert